Last update 01 Nov 2024

Insmed Netherlands BV

Subsidiary Company|
Netherlands

Overview

Tags

Congenital Disorders
Other Diseases
Infectious Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases2
Top 5 Drug TypeCount
Small molecule drug2
Top 5 TargetCount
30S subunit(30S ribosomal subunit)1
DPP-1(Cathepsin C)1

Related

2
Drugs associated with Insmed Netherlands BV
Amikacin Sulfate
Target
30S subunit
Mechanism
30S subunit inhibitors
Active Org.
Insmed, Inc.Insmed, Inc. [+4]
Originator Org.
Hubei Huazhong Pharmaceutical Co. Ltd.Hubei Huazhong Pharmaceutical Co. Ltd.
Active Indication
Mycobacterium Infections, Nontuberculous [+7]
Inactive Indication
Bronchiectasis [+8]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
CN
First Approval Date01 Jan 1981
Brensocatib
Target
DPP-1
Mechanism
DPP-1 inhibitors
Active Org.
Insmed, Inc.Insmed, Inc. [+1]
Originator Org.
AstraZeneca PLCAstraZeneca PLC
Active Indication
Non-cystic fibrosis bronchiectasis [+6]
Inactive Indication
COVID-19
Drug Highest PhasePhase 3
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Insmed Netherlands BV
Login to view more data
0 Patents (Medical) associated with Insmed Netherlands BV
Login to view more data
100 Deals associated with Insmed Netherlands BV
Login to view more data
100 Translational Medicine associated with Insmed Netherlands BV
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2 Clinical
1
1
Approved
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Amikacin Sulfate
 ( 30S subunit )		Mycobacterium Infections, Nontuberculous
More
Approved
Brensocatib
 ( DPP-1 )		Hidradenitis Suppurativa
More
Phase 2
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free